Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

A new study has found intermittent fasting could slow, or even reverse, the progression of Alzheimer’s disease.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Aside from the potential curse of long COVID, people who've had the SARS-CoV-2 virus may be more likely to develop high ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy ...

Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

A recent study published in eLife offers a new perspective on the development of Alzheimer’s disease, suggesting that the ...

Diabetes is a common, lifelong condition that occurs when the pancreas doesn't produce enough insulin, or when the body is unable to effectively use the insulin it produces ...

The virtual presentation is hosted by the Alzheimer’s Association and North Dakota State University Extension.